215
Views
13
CrossRef citations to date
0
Altmetric
Research Article

The impact of preparation parameters on typical attributes of chitosan-heparin nanohydrogels: particle size, loading efficiency, and drug release

&
Pages 1774-1782 | Received 24 Jul 2012, Accepted 01 Oct 2012, Published online: 09 Nov 2012

References

  • Hamidi M, Azadi A, Rafiei P. (2008). Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev, 60:1638–1649.
  • Vaghani SS, Patel MM. (2011). pH-sensitive hydrogels based on semi-interpenetrating network (semi-IPN) of chitosan and polyvinyl pyrrolidone for clarithromycin release. Drug Dev Ind Pharm, 37:1160–1169.
  • Zhang LL, Li P, Li YM, Wang AQ. (2012). Preparation and characterization of magnetic alginate-chitosan hydrogel beads loaded matrine. Drug Dev Ind Pharm, 38:872–882.
  • Jung T, Kamm W, Breitenbach A, Kaiserling E, Xiao JX, Kissel T. (2000). Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? Eur J Pharm Biopharm, 50:147–160.
  • Hu X, Jing X. (2009). Biodegradable amphiphilic polymer-drug conjugate micelles. Expert Opin Drug Deliv, 6:1079–1090.
  • Lu Z, Chen W, Hamman JH. (2010). Chitosan-polycarbophil interpolyelectrolyte complex as a matrix former for controlled release of poorly water-soluble drugs I: in vitro evaluation. Drug Dev Ind Pharm, 36:539–546.
  • Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. (2008). Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. J Control Release, 125:193–209.
  • Upadhyay KK, Agrawal HG, Upadhyay C, Schatz C, Le Meins JF, Misra A et al. (2009). Role of block copolymer nanoconstructs in cancer therapy. Crit Rev Ther Drug Carrier Syst, 26:157–205.
  • Prabaharan M, Grailer JJ, Steeber DA, Gong S. (2008). Stimuli-responsive chitosan-graft-poly(N-vinylcaprolactam) as a promising material for controlled hydrophobic drug delivery. Macromol Biosci, 8:843–851.
  • Ganta S, Devalapally H, Shahiwala A, Amiji M. (2008). A review of stimuli-responsive nanocarriers for drug and gene delivery. J Control Release, 126:187–204.
  • Arias JL, López-Viota M, Gallardo V, Adolfina Ruiz M. (2010). Chitosan nanoparticles as a new delivery system for the chemotherapy agent tegafur. Drug Dev Ind Pharm, 36:744–750.
  • Wang XL, Huang Y, Zhu J, Pan YB, He R, Wang YZ. (2009). Chitosan-graft poly(p-dioxanone) copolymers: preparation, characterization, and properties. Carbohydr Res, 344:801–807.
  • Chen MC, Wong HS, Lin KJ, Chen HL, Wey SP, Sonaje K et al. (2009). The characteristics, biodistribution and bioavailability of a chitosan-based nanoparticulate system for the oral delivery of heparin. Biomaterials, 30:6629–6637.
  • Lin YH, Chang CH, Wu YS, Hsu YM, Chiou SF, Chen YJ. (2009). Development of pH-responsive chitosan/heparin nanoparticles for stomach-specific anti-Helicobacter pylori therapy. Biomaterials, 30:3332–3342.
  • Nguyen MK, Lee DS. (2010). Injectable biodegradable hydrogels. Macromol Biosci, 10:563–579.
  • Leucuta SE. (2010). Nanotechnology for delivery of drugs and biomedical applications. Curr Clin Pharmacol, 5:257–280.
  • Li P, Zhang N. (2011). Layer-by-layer self-assembly vectors for gene delivery. Curr Gene Ther, 11:58–73.
  • Nagpal K, Singh SK, Mishra DN. (2010). Chitosan nanoparticles: a promising system in novel drug delivery. Chem Pharm Bull, 58:1423–1430.
  • Saha RN, Vasanthakumar S, Bende G, Snehalatha M. (2010). Nanoparticulate drug delivery systems for cancer chemotherapy. Mol Membr Biol, 27:215–231.
  • Giannotti MI, Esteban O, Oliva M, García-Parajo MF, Sanz F. (2011). pH-responsive polysaccharide-based polyelectrolyte complexes as nanocarriers for lysosomal delivery of therapeutic proteins. Biomacromolecules, 12:2524–2533.
  • Oyarzun-Ampuero FA, Brea J, Loza MI, Alonso MJ, Torres D. (2012). A potential nanomedicine consisting of heparin-loaded polysaccharide nanocarriers for the treatment of asthma. Macromol Biosci, 12:176–183.
  • Codée JD, Stubba B, Schiattarella M, Overkleeft HS, van Boeckel CA, van Boom JH et al. (2005). A modular strategy toward the synthesis of heparin-like oligosaccharides using monomeric building blocks in a sequential glycosylation strategy. J Am Chem Soc, 127:3767–3773.
  • Jee KS, Park HD, Park KD, Kim YH, Shin JW. (2004). Heparin conjugated polylactide as a blood compatible material. Biomacromolecules, 5:1877–1881.
  • Luppi E, Cesaretti M, Volpi N. (2005). Purification and characterization of heparin from the Italian clam Callista chione. Biomacromolecules, 6:1672–1678.
  • Suk JY, Zhang F, Balch WE, Linhardt RJ, Kelly JW. (2006). Heparin accelerates gelsolin amyloidogenesis. Biochemistry, 45:2234–2242.
  • Hamidi M, Shahbazi MA, Rostamizadeh K. (2012). Copolymers: efficient carriers for intelligent nanoparticulate drug targeting and gene therapy. Macromol Biosci, 12:144–164.
  • Shahbazi MA, Santos HA. (2012). Improving oral absorption via drug-loaded nanocarriers: absorption mechanisms, intestinal models and rational fabrication. Curr Drug Metab.
  • Li XY, Li X, Kong XY, Shi S, Guo G, Zhang J et al. (2010). Preparation of N-trimethyl chitosan-protein nanoparticles intended for vaccine delivery. J Nanosci Nanotechnol, 10:4850–4858.
  • Santander-Ortega MJ, Peula-García JM, Goycoolea FM, Ortega-Vinuesa JL. (2011). Chitosan nanocapsules: Effect of chitosan molecular weight and acetylation degree on electrokinetic behaviour and colloidal stability. Colloids Surf B Biointerfaces, 82:571–580.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.